{"id":"W2076653959","doi":"10.1186/1756-0500-6-82","title":"Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010","year":2013,"lang":"en","type":"article","venue":"BMC Research Notes","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Medical prescription; Adverse effect; Pharmacy; Emergency medicine; Demography; Database; Internal medicine; Family medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005022616,0.0001311368,0.0001631113,0.00008940694,0.00009348081,0.0000587175,0.0001183734,0.0001450051,0.00003506274],"category_scores_gemma":[0.002168341,0.0001175548,0.00001886209,0.0001757746,0.0001299592,0.00002196028,0.0002055047,0.0002678819,0.000006564379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001522503,"about_ca_system_score_gemma":0.0007202302,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.633885,"about_ca_topic_score_gemma":0.5908538,"domain_scores_codex":[0.9984126,0.0003201959,0.000188497,0.000341279,0.0002661188,0.000471299],"domain_scores_gemma":[0.9990409,0.0003082872,0.00003845114,0.0001949807,0.0002013783,0.0002160307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00001737619,0.00001776955,0.745636,0.00001214958,0.00002170725,0.000001364023,0.00001809817,0.000009657879,0.2523908,9.92312e-7,0.001535802,0.0003382774],"study_design_scores_gemma":[0.0005072415,0.00009403475,0.6950936,0.00002477083,0.000002639089,0.000001047992,0.000121341,0.00007681171,0.3034862,0.00003914236,0.0004158454,0.0001372625],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984875,0.0008045335,0.00001407257,0.0002320355,0.00003872827,0.0003624726,0.00004391004,0.000005037235,0.00001170106],"genre_scores_gemma":[0.9991074,0.0002593113,0.0001486249,0.00003307274,0.00006182413,0.00005966301,0.00007568329,0.00001919264,0.0002351945],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05109546,"threshold_uncertainty_score":0.4793745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06498338321101246,"score_gpt":0.3274777053683683,"score_spread":0.2624943221573559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}